Jane Street
VOR icon

Jane Street’s Vor Biopharma VOR Stock Holding History

Jane Street’s Portfolio VOR Stock Details VOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.35M Sell
75,890
-15,920
-17% -$225K ﹤0.01% 5841
2025
Q4 		$1.2M Buy
91,810
+75,057
+448% +$1.4M ﹤0.01% 5764
2025
Q3 		$816K Sell
16,753
-9,528
-36% -$383K ﹤0.01% 6766
2025
Q2 		$851K Buy
26,281
+16,543
+170% +$146K ﹤0.01% 5918
2025
Q1 		$140K Buy
+9,738
New +$234K ﹤0.01% 8654
2024
Q4 		– Sell
-688
Closed -$9.63K – 10700
2024
Q3 		$9.63K Sell
688
-10,437
-94% -$190K ﹤0.01% 9357
2024
Q2 		$223K Buy
11,125
+10,150
+1,041% +$328K ﹤0.01% 8230
2024
Q1 		$46.2K Buy
975
+128
+15% +$5.62K ﹤0.01% 8754
2023
Q4 		$38.1K Buy
+847
New +$35K ﹤0.01% 8829
2023
Q3 		– Sell
-4,623
Closed -$286K – 9475
2023
Q2 		$286K Sell
4,623
-1,833
-28% -$167K ﹤0.01% 7202
2023
Q1 		$695K Buy
6,456
+3,036
+89% +$336K ﹤0.01% 5731
2022
Q4 		$455K Buy
3,420
+2,899
+556% +$287K ﹤0.01% 6299
2022
Q3 		$41K Buy
+521
New +$51.2K ﹤0.01% 9003

Other funds holding VOR

TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Jane Street's VOR Position: Q1 2026 in Review

Jane Street reduced its Vor Biopharma (VOR) stake by 17% in Q1 2026, selling an estimated $225K and leaving 75,890 shares worth $1.35M. The position accounts for ﹤0.01% of the portfolio, ranked #5841.

Jane Street first reported a position in VOR in Q3 2022 and has held it in 13 quarters since. 80 funds tracked by Wall St. Rank hold VOR as of Q1 2026.

  • Jane Street held 75,890 shares of Vor Biopharma worth $1.35M as of Q1 2026.
  • Jane Street sold 15,920 Vor Biopharma shares in Q1 2026, an estimated $225K.
  • Vor Biopharma made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #5841 holding.
  • Jane Street first reported a position in Vor Biopharma in Q3 2022 and has held it in 13 quarters since.
  • 80 funds tracked by Wall St. Rank held Vor Biopharma as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.